Copyright Reports & Markets. All rights reserved.

Global and United States Breast Cancer Liquid Biopsy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Circulating Tumor Cells (CTCs)
    • 1.2.3 Cell-Free DNA (CfDNA)
    • 1.2.4 Extracellular Vesicles (EVs)
    • 1.2.5 Other Circulating Biomarkers
  • 1.3 Market by Application
    • 1.3.1 Global Breast Cancer Liquid Biopsy Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Diagnostic Centers
    • 1.3.4 Laboratories
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Breast Cancer Liquid Biopsy Market Perspective (2015-2026)
  • 2.2 Global Breast Cancer Liquid Biopsy Growth Trends by Regions
    • 2.2.1 Breast Cancer Liquid Biopsy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Breast Cancer Liquid Biopsy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Breast Cancer Liquid Biopsy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Breast Cancer Liquid Biopsy Players by Market Size
    • 3.1.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue (2015-2020)
    • 3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2015-2020)
  • 3.2 Global Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Breast Cancer Liquid Biopsy Revenue
  • 3.4 Global Breast Cancer Liquid Biopsy Market Concentration Ratio
    • 3.4.1 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Liquid Biopsy Revenue in 2019
  • 3.5 Key Players Breast Cancer Liquid Biopsy Area Served
  • 3.6 Key Players Breast Cancer Liquid Biopsy Product Solution and Service
  • 3.7 Date of Enter into Breast Cancer Liquid Biopsy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Breast Cancer Liquid Biopsy Breakdown Data by Type (2015-2026)

  • 4.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Type (2015-2020)
  • 4.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2021-2026)

5 Breast Cancer Liquid Biopsy Breakdown Data by Application (2015-2026)

  • 5.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Application (2015-2020)
  • 5.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Breast Cancer Liquid Biopsy Market Size (2015-2026)
  • 6.2 North America Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 6.3 North America Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 6.4 North America Breast Cancer Liquid Biopsy Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Breast Cancer Liquid Biopsy Market Size (2015-2026)
  • 7.2 Europe Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 7.3 Europe Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 7.4 Europe Breast Cancer Liquid Biopsy Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Breast Cancer Liquid Biopsy Market Size (2015-2026)
  • 8.2 China Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 8.3 China Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 8.4 China Breast Cancer Liquid Biopsy Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Breast Cancer Liquid Biopsy Market Size (2015-2026)
  • 9.2 Japan Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 9.3 Japan Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 9.4 Japan Breast Cancer Liquid Biopsy Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Breast Cancer Liquid Biopsy Market Size (2015-2026)
  • 10.2 Southeast Asia Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Breast Cancer Liquid Biopsy Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 QIAGEN
    • 11.1.1 QIAGEN Company Details
    • 11.1.2 QIAGEN Business Overview
    • 11.1.3 QIAGEN Breast Cancer Liquid Biopsy Introduction
    • 11.1.4 QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2015-2020))
    • 11.1.5 QIAGEN Recent Development
  • 11.2 Roche Diagnostics
    • 11.2.1 Roche Diagnostics Company Details
    • 11.2.2 Roche Diagnostics Business Overview
    • 11.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Introduction
    • 11.2.4 Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 11.2.5 Roche Diagnostics Recent Development
  • 11.3 Bio-Rad Laboratories
    • 11.3.1 Bio-Rad Laboratories Company Details
    • 11.3.2 Bio-Rad Laboratories Business Overview
    • 11.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Introduction
    • 11.3.4 Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 11.3.5 Bio-Rad Laboratories Recent Development
  • 11.4 Myriad Genetics
    • 11.4.1 Myriad Genetics Company Details
    • 11.4.2 Myriad Genetics Business Overview
    • 11.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Introduction
    • 11.4.4 Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 11.4.5 Myriad Genetics Recent Development
  • 11.5 Menarini Silicon Biosystems
    • 11.5.1 Menarini Silicon Biosystems Company Details
    • 11.5.2 Menarini Silicon Biosystems Business Overview
    • 11.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Introduction
    • 11.5.4 Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 11.5.5 Menarini Silicon Biosystems Recent Development
  • 11.6 Genomic Health
    • 11.6.1 Genomic Health Company Details
    • 11.6.2 Genomic Health Business Overview
    • 11.6.3 Genomic Health Breast Cancer Liquid Biopsy Introduction
    • 11.6.4 Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 11.6.5 Genomic Health Recent Development
  • 11.7 Thermo Fisher Scientific
    • 11.7.1 Thermo Fisher Scientific Company Details
    • 11.7.2 Thermo Fisher Scientific Business Overview
    • 11.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Introduction
    • 11.7.4 Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 11.7.5 Thermo Fisher Scientific Recent Development
  • 11.8 Illumina
    • 11.8.1 Illumina Company Details
    • 11.8.2 Illumina Business Overview
    • 11.8.3 Illumina Breast Cancer Liquid Biopsy Introduction
    • 11.8.4 Illumina Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 11.8.5 Illumina Recent Development
  • 11.9 Biocept
    • 11.9.1 Biocept Company Details
    • 11.9.2 Biocept Business Overview
    • 11.9.3 Biocept Breast Cancer Liquid Biopsy Introduction
    • 11.9.4 Biocept Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 11.9.5 Biocept Recent Development
  • 11.10 Trovagene
    • 11.10.1 Trovagene Company Details
    • 11.10.2 Trovagene Business Overview
    • 11.10.3 Trovagene Breast Cancer Liquid Biopsy Introduction
    • 11.10.4 Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 11.10.5 Trovagene Recent Development
  • 11.11 Guardant Health
    • 10.11.1 Guardant Health Company Details
    • 10.11.2 Guardant Health Business Overview
    • 10.11.3 Guardant Health Breast Cancer Liquid Biopsy Introduction
    • 10.11.4 Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 10.11.5 Guardant Health Recent Development
  • 11.12 RainDance Technologies
    • 10.12.1 RainDance Technologies Company Details
    • 10.12.2 RainDance Technologies Business Overview
    • 10.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Introduction
    • 10.12.4 RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 10.12.5 RainDance Technologies Recent Development
  • 11.13 MDx Health
    • 10.13.1 MDx Health Company Details
    • 10.13.2 MDx Health Business Overview
    • 10.13.3 MDx Health Breast Cancer Liquid Biopsy Introduction
    • 10.13.4 MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
    • 10.13.5 MDx Health Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Breast Cancer Liquid Biopsy Scope and Market Size
    Breast Cancer Liquid Biopsy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Circulating Tumor Cells (CTCs)
    Cell-Free DNA (CfDNA)
    Extracellular Vesicles (EVs)
    Other Circulating Biomarkers

    Market segment by Application, split into
    Hospitals
    Diagnostic Centers
    Laboratories

    Based on regional and country-level analysis, the Breast Cancer Liquid Biopsy market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Breast Cancer Liquid Biopsy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    QIAGEN
    Roche Diagnostics
    Bio-Rad Laboratories
    Myriad Genetics
    Menarini Silicon Biosystems
    Genomic Health
    Thermo Fisher Scientific
    Illumina
    Biocept
    Trovagene
    Guardant Health
    RainDance Technologies
    MDx Health

    Buy now